AstraZeneca Pharmaceuticals LP
Real-world evidence at ECCMID 2024 further substantiates the continued[...]
10/20/2021 | Press release | Distributed by Public on 10/20/2021 11:15
(Aprobada por el Consejo Permanente de la OEA en la sesión ordinaria virtual celebrada el 20 de octubre de 2021)
RESOLUCIÓN.
Referencia: D-010/21
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact